Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Journal of Cancer
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Sanofi
OpenAlex ID: W1976156924
